CVS Caremark To Place Novo Nordisk's Wegovy On Preferred Coverage For GLP-1 Weight Loss Treatment
1. CVS will prefer Wegovy on its formularies from July 2025. 2. Novo Nordisk promotes Wegovy for obesity treatment and cardiovascular risk reduction. 3. Wegovy is priced at $499/month for self-paying patients. 4. Novo Nordisk explores ways to enhance Wegovy access for CVS customers. 5. Hims & Hers offer Wegovy prescriptions at $599/month.